Montserrat Torrebadell

Montserrat Torrebadell

UNVERIFIED PROFILE

Are you Montserrat Torrebadell?   Register this Author

Register author
Montserrat Torrebadell

Montserrat Torrebadell

Publications by authors named "Montserrat Torrebadell"

Are you Montserrat Torrebadell?   Register this Author

15Publications

466Reads

14Profile Views

A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia.

Leuk Lymphoma 2018 10 2;59(10):2394-2404. Epub 2018 Feb 2.

c Hematology Department , Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1422859DOI Listing
October 2018

Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier.

J Control Release 2017 Oct 19;264:34-44. Epub 2017 Aug 19.

Institut de Recerca Sant Joan de Deu, Barcelona, Spain; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Deu, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2017.08.018DOI Listing
October 2017

Aplastic Crisis Secondary to Parvovirus B19 Infection as the First Manifestation of an Undiagnosed Hereditary Spherocytosis: Report of a Pediatric Series of Spanish Patients.

J Pediatr Hematol Oncol 2016 Jan;38(1):81-2

*Department of Pediatric Hematology and Oncology †Laboratory Department, Molecular Genetics, Hospital Sant Joan de Déu de Barcelona, University of Barcelona Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000481DOI Listing
January 2016

Microbial translocation and T cell activation are not associated in chronic HIV-infected children.

AIDS 2014 Aug;28(13):1989-92

aUnidad de Enfermedades Infecciosas e Inmunopatologias, Hospital Infantil Virgen del Rocio, Instituto de Biomedicina de Sevilla, Sevilla bUnitat d'Infectologia, Servei de Pediatria, Hospital Sant Joan de Déu - Universitat de Barcelona, Barcelona cCentre for International Health Research, Barcelona dUnidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocío/Instituto de Biomedicina de Sevilla (IBiS), Sevilla eServei d'Hematologia, Hospital Sant Joan de Déu - Universitat de Barcelona, Barcelona fServicio de Inmunología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Sevilla gServei de Laboratori Hospital Sant Joan de Déu Universitat de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000375DOI Listing
August 2014

Long-term results of thalidomide in refractory and relapsed multiple myeloma with emphasis on response duration.

Eur J Haematol 2006 Dec 15;77(6):486-92. Epub 2006 Sep 15.

Hematology Department, Institute of Hematology and Oncology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Villarroel, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.0902-4441.2006.t01-1-EJH2783.xDOI Listing
December 2006